Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

GABAPENTIN ATTENUATES THE PRESSOR RESPONSE TO DIRECT LARYNGOSCOPY AND TRACHEAL INTUBATION

NCT06705101 is registered in ClinicalTrials.gov with Liaquat National Hospital & Medical College as lead sponsor.

NCT NCT06705101
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06705101 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
GABAPENTIN ATTENUATES THE PRESSOR RESPONSE TO DIRECT LARYNGOSCOPY AND TRACHEAL INTUBATION
Lead sponsor
Liaquat National Hospital & Medical College
Phase
Phase 1/2
Overall status
Not yet recruiting
Start date
December 15, 2024
Completion date
July 16, 2025
Enrollment
144 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

blood pressure, elective surgical patients